EAM Investors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,256
Closed -$2.36M 326
2023
Q2
$2.36M Buy
+7,256
New +$2.07M 0.44% 88
2023
Q1
Sell
-7,648
Closed -$1.93M 313
2022
Q4
$1.93M Buy
+7,648
New +$1.63M 0.4% 98
2021
Q4
Sell
-9,993
Closed -$2.33M 323
2021
Q3
$2.33M Buy
+9,993
New +$2.09M 0.39% 83
2021
Q2
Sell
-9,632
Closed -$1.99M 364
2021
Q1
$1.99M Sell
9,632
-1,811
-16% -$385K 0.3% 133
2020
Q4
$2.15M Sell
11,443
-12,479
-52% -$2.04M 0.35% 99
2020
Q3
$3.09M Sell
23,922
-6,004
-20% -$662K 0.73% 18
2020
Q2
$2.6M Sell
29,926
-18,247
-38% -$1.4M 0.58% 46
2020
Q1
$2.9M Buy
48,173
+18,591
+63% +$1.38M 0.9% 12
2019
Q4
$2.19M Sell
29,582
-11,963
-29% -$769K 0.48% 68
2019
Q3
$2.54M Sell
41,545
-327
-0.8% -$21.5K 0.67% 33
2019
Q2
$2.54M Sell
41,872
-8,122
-16% -$438K 0.62% 42
2019
Q1
$2.84M Sell
49,994
-16,704
-25% -$903K 0.7% 31
2018
Q4
$2.82M Sell
66,698
-29,789
-31% -$1.27M 0.77% 24
2018
Q3
$4.06M Sell
96,487
-6,169
-6% -$290K 0.6% 30
2018
Q2
$3.66M Buy
+102,656
New +$3.31M 0.58% 42

Other funds holding INSP

EAM Investors's INSP Position: Q3 2023 in Review

EAM Investors sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 7,256 shares — an estimated $2.36M sold.

EAM Investors first reported a position in INSP in Q2 2018 and held it in 15 quarters. The position peaked at $4.06M in Q3 2018. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • EAM Investors reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • EAM Investors sold 7,256 Inspire Medical Systems shares in Q3 2023, an estimated $2.36M.
  • EAM Investors first reported a position in Inspire Medical Systems in Q2 2018 and held it in 15 quarters.
  • EAM Investors's Inspire Medical Systems position peaked at $4.06M in Q3 2018.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on EAM Investors's 13F filing for Q3 2023, filed 13 Nov 2023.